Biotron Limited Stock Market Value
| BITRF Stock | USD 0.01 0.00 0.00% |
| Symbol | Biotron |
Biotron 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Biotron's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Biotron.
| 05/08/2023 |
| 11/28/2024 |
If you would invest 0.00 in Biotron on May 8, 2023 and sell it all today you would earn a total of 0.00 from holding Biotron Limited or generate 0.0% return on investment in Biotron over 570 days. Biotron is related to or competes with Covalon Technologies, Mosaic Immunoengineerin, and Cellectis. Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat var... More
Biotron Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Biotron's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Biotron Limited upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.11) | |||
| Maximum Drawdown | 62.53 | |||
| Value At Risk | (5.84) | |||
| Potential Upside | 1.34 |
Biotron Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Biotron's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Biotron's standard deviation. In reality, there are many statistical measures that can use Biotron historical prices to predict the future Biotron's volatility.| Risk Adjusted Performance | (0.07) | |||
| Jensen Alpha | (0.69) | |||
| Total Risk Alpha | (2.43) | |||
| Treynor Ratio | 0.443 |
Biotron Limited Backtested Returns
Biotron Limited secures Sharpe Ratio (or Efficiency) of -0.1, which signifies that the company had a -0.1% return per unit of risk over the last 3 months. Biotron Limited exposes nineteen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Biotron's Risk Adjusted Performance of (0.07), standard deviation of 9.39, and Mean Deviation of 3.09 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of -2.15, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Biotron are expected to decrease by larger amounts. On the other hand, during market turmoil, Biotron is expected to outperform it. At this point, Biotron Limited has a negative expected return of -0.99%. Please make sure to confirm Biotron's variance, value at risk, as well as the relationship between the Value At Risk and rate of daily change , to decide if Biotron Limited performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.7 |
Very good reverse predictability
Biotron Limited has very good reverse predictability. Overlapping area represents the amount of predictability between Biotron time series from 8th of May 2023 to 17th of February 2024 and 17th of February 2024 to 28th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Biotron Limited price movement. The serial correlation of -0.7 indicates that around 70.0% of current Biotron price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.7 | |
| Spearman Rank Test | -0.54 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Biotron Limited lagged returns against current returns
Autocorrelation, which is Biotron pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Biotron's pink sheet expected returns. We can calculate the autocorrelation of Biotron returns to help us make a trade decision. For example, suppose you find that Biotron has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Biotron regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Biotron pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Biotron pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Biotron pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Biotron Lagged Returns
When evaluating Biotron's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Biotron pink sheet have on its future price. Biotron autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Biotron autocorrelation shows the relationship between Biotron pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Biotron Limited.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in Biotron Pink Sheet
Biotron financial ratios help investors to determine whether Biotron Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biotron with respect to the benefits of owning Biotron security.